Tumor-associated macrophage-derived exosomes modulate the immunotherapeutic sensitivity of SHH-medulloblastoma by targeting m6A-modified FOXD1
Authors:
Open Access
- 22 May 2025
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 27 (11) , 3000-3015
Abstract
Background: Medulloblastoma (MB) is the most common pediatric malignant brain tumor. Infiltration of tumor-associated macrophages (TAMs) and m6A modification of RNA are correlated with poor prognosis and tumor progression in the Sonic Hedgehog (SHH) subtype (SHH-MB). However, the relationship between TAMs infiltration in SHH-MB and m6A modification status during tumor progression remains unclear. Methods: Expression of m6A modification-related proteins was assessed in 40 cases of SHH-MB. Genes affected by TAM-derived exosomes were identified with methylated RNA immunoprecipitation sequencing. Mechanisms of m6A modification of FOXD1 were evaluated and combinatorial treatment with AAV2/9-shFOXD1 and PD-1 inhibitors was investigated in the NeuroD2:SmoA1 mouse model. Results: TAMs infiltration led to decreased METTL14 expression, which was mediated by TAM-derived exosomes containing METTL14-specific microRNAs. In turn, this led to lower levels of m6A modifications. Through a screen, FOXD1 was identified as a critical downstream target of TAM-derived exosomes, and its expression level was correlated with poor prognosis in SHH-MBs. Importantly, knockdown of FOXD1 in SHH-MB cells significantly promoted the release of chemokines CXCL10/11, resulting in CD8+ T cell recruitment. Furthermore, treatment with AAV2/9-shFOXD1 significantly enhanced the antitumor effect of the PD-1 inhibitor in transgenic SHH-MB mice. Conclusions: Our study revealed for the first time that TAM-derived exosomes modulate m6A levels in SHH-MB, which promotes tumor progression via FOXD1. We identified FOXD1 as a novel therapeutic target whose inhibition sensitizes SHH-MB to immune checkpoint blockade.Keywords
Funding Information
- Natural Science Foundation (7232098)
- Natural Science Foundation (7192095)
This publication has 38 references indexed in Scilit:
- Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunityCell Reports, 2023
- Dissecting multifunctional roles of forkhead box transcription factor D1 in cancersBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023
- METTL3 regulates m6A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastomaCell Reports, 2022
- The Critical Role of RNA m6A Methylation in Gliomas: Targeting the Hallmarks of CancerCellular and Molecular Neurobiology, 2022
- Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastomaCancer Letters, 2022
- RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathwayAngiogenesis, 2020
- Rethinking medulloblastoma from a targeted therapeutics perspectiveJournal of Neuro-Oncology, 2018
- Assessment of programmed death‐ligand 1 expression and tumor‐associated immune cells in pediatric cancer tissuesCancer, 2017
- Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastomaJournal of Neuro-Oncology, 2016
- N6-methyladenosine Modulates Messenger RNA Translation EfficiencyCell, 2015